Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zibo Wanjie Pharmaceutical Co., Ltd. is a prominent pharmaceutical manufacturer based in Zibo, Shandong Province, China, and operates as a subsidiary of the Wanjie Group. The company specializes in the development and production of a diverse range of healthcare products, including chemical synthetic drugs and traditional Chinese medicines. Its extensive portfolio features various dosage forms such as large and small volume injections, tablets, and capsules, targeting therapeutic areas like cardiovascular disease and infectious disorders. Zibo Wanjie Pharmaceutical maintains rigorous quality standards with multiple GMP-certified production facilities. The company serves a broad market, providing both active pharmaceutical ingredients and finished formulations to domestic and international clients. As part of a larger conglomerate with interests in specialized medical services, the company benefits from integrated healthcare resources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zibo Wanjie Pharmaceutical.